In Vitro and In Vivo Anticancer Activity of Gimatecan against Hepatocellular Carcinoma

OBJECTIVE: Gimatecan is a new camptothecin (CPT) analogue that inhibits tumor growth by targeting DNA topoisomerase I (TOP I) and introducing strong and persistent DNA cleavage. Anti-tumor activity has been demonstrated with a wide range of solid tumors in previous preclinical and clinical studies....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Youna, Lau, Lit-Fui, Dai, Xiangrong, Li, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454685/
https://www.ncbi.nlm.nih.gov/pubmed/28030910
http://dx.doi.org/10.22034/APJCP.2016.17.11.4853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454685/
https://www.ncbi.nlm.nih.gov/pubmed/28030910
http://dx.doi.org/10.22034/APJCP.2016.17.11.4853

Ejemplares similares